Brainsway Ltd. (BWAY) stock
BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
$10.25−0.99 (-8.81%)
Close on Nov 12, 2026Market cap $401.45MP/E 56.9Yield –
Brainsway ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Brainsway's ebitda for the twelve months ending Dec 31, 2020 was -$4.39M. For fiscal 2025 it was $4.99M, up 143.2% from the year before. The highest annual figure on record is $4.99M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.99M | +143.2% |
| FY2024 | Dec 31, 2024 | $2.05M | – |
| FY2023 | Dec 31, 2023 | -$4.60M | – |
| FY2022 | Dec 31, 2022 | -$12.13M | – |
| FY2021 | Dec 31, 2021 | -$4.44M | – |
| FY2020 | Dec 31, 2020 | -$4.39M | – |
| FY2019 | Dec 31, 2019 | -$7.93M | – |
| FY2018 | Dec 31, 2018 | -$4.65M | – |
| FY2017 | Dec 31, 2017 | -$6.22M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -$10.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.81M | – |
See a number that looks wrong?